Clinical significance of novel urinary markers for the diagnosis, staging, and the prediction of prognosis in patients with prostate cancer

Clinical significance of novel urinary markers for the diagnosis, staging, and the prediction of prognosis in patients with prostate cancer - Clinical significance of novel urinary markers in prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000001313

Enrollment

500

Registered

2008-08-14

Start date

2008-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: The patients who undergo needle biopsy of the prostate and the patients who diagnosed as prostate cancer

Exclusion criteria

Exclusion criteria: The patients who do not have anus because prostate massage is not possible during the procedure to get samples

Design outcomes

Primary

Measure	Time frame
To evaluate the association between urinary markers and 1)presence or absence of prostate cancer, 2)cinical staging, 3)pathological staging (TNM clasification), 4)PSA recurrence, and 5)prognosis	—

Countries

Japan

Outcome results